Jaguarhealth.gcs-web.com

Investor Overview Jaguar Health, Inc.

WebJaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably …

Actived: 3 days ago

URL: https://jaguarhealth.gcs-web.com/

News Release Details

WebJaguar planning for launch of Canalevia ™ for CID in dogs this December. Canalevia is the first and only oral plant-based prescription drug candidate for CID in …

Category:  Health Go Health

Jaguar Health Announces Topline Results of Investigator-Initiated …

WebCrofelemer is a novel, oral plant-based non-opioid antidiarrheal medication. SAN FRANCISCO, CA / ACCESSWIRE / November 19, 2021 / Jaguar Health, Inc. …

Category:  Health Go Health

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for

WebCanalevia ®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA. Crofelemer, …

Category:  Health Go Health

News Release Details

WebPrimary endpoint based on patient reported outcomes from study expected in October 2023. With the completion of the PIPE financing of unregistered shares and 6 …

Category:  Health Go Health

News Release Details

WebCost of Product Revenue: Total cost of product revenue for the quarter ended September 30, 2022 was the same amount at $0.6 million for the quarter ended …

Category:  Health Go Health

Jaguar Animal Health to Host Treatment Forum for Veterinarians …

WebCanalevia ™-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of …

Category:  Health Go Health

Jaguar Health, Inc.

WebEstimated annual US revenue for Takeda’s SBS drug Gattex: ~$555 million. Global SBS market projected to reach $4.6 billion by 2027 with a CAGR of 26% from …

Category:  Health Go Health

Jaguar Health Files First Quarterly Earnings Report Since July 2017

WebAs a Result of the Merger, Jaguar Shows Positive Net Income for Q3 2017. SAN FRANCISCO--(BUSINESS WIRE)--Nov. 20, 2017-- Jaguar Health, Inc. (NASDAQ: …

Category:  Health Go Health

Napo Pharmaceuticals, a Jaguar Health Family Company, Accepted …

WebNapo Pharmaceuticals, a Jaguar Health Family Company, Accepted to Present Results of Its Pivotal Phase 3 OnTarget Study for Preventive Treatment of …

Category:  Health Go Health

Magdalena Biosciences, a Joint Venture between Jaguar Health …

WebMagdalena Biosciences, a joint venture recently formed by Jaguar Health and Filament Health Corp., is focused on developing novel, natural prescription …

Category:  Health Go Health

Napo Pharmaceuticals, a Jaguar Health Company, Announces …

WebThe Investor Relations website contains information about Jaguar Health, Inc.'s business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

Historical Price Lookup Jaguar Health, Inc.

WebMay 7, 2024. $0.30. 44,179,699. 1:1. $0.29. $0.30. $0.27. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits …

Category:  Health Go Health

Press Releases Jaguar Health, Inc.

Web03/27/24. Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates. 03/20/24. GEN to Commercialize …

Category:  Health Go Health

Jaguar Health Announces Submission of Orphan Drug Designation

WebCholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae. Crofelemer previously granted Orphan Drug Designation …

Category:  Health Go Health

Jaguar Health Provides Corporate Update and Outlines 2022 …

Web2021 was a year of progress for Jaguar Health as the company advanced its key human pipeline initiatives focused on chemotherapy-related diarrhea (CTD) and …

Category:  Health Go Health

Jaguar Health Announces FDA Activation of Third-Party …

WebNapo Pharmaceuticals, a Jaguar Health company and the manufacturer of crofelemer, is supporting this physician-generated IND. SAN FRANCISCO, CA / …

Category:  Health Go Health

Jaguar Health Enters Exclusive Crofelemer Revenue Sharing …

WebQuadri Pharma will cover 50% of the costs of development activity up to a capped dollar contribution. Jaguar to host virtual educational webinar on intestinal failure …

Category:  Health Go Health

Jaguar Health Appoints European Pharmaceutical Industry Leader …

WebDr. Massimo Radaelli's core focus will be on further expanding Jaguar's commercial footprint outside the U.S. Dr. Radaelli was instrumental in facilitating the …

Category:  Health Go Health

jaguarhealth.gcs-web.com

WebUNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. SCHEDULE 13D. Under the Securities Exchange Act of 1934 (Amendment No. …

Category:  Health Go Health